human prostate cancer antigen 3
target for therapy in prostate cancer; DD3/PCA3 is a highly prostate cancer-specific gene; has been sequenced
Also Known As:
prostate cancer antigen 3, human; DD3 antigen, human; PCA3, human; differential display code 3 antigen, human
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | He, Wei:
1 article
(10/2018)
|
| 2. | Hu, Yingfang:
1 article
(10/2018)
|
| 3. | Ji, Alin:
1 article
(10/2018)
|
| 4. | Mao, Zujie:
1 article
(10/2018)
|
| 5. | Xie, Liping:
1 article
(10/2018)
|
| 6. | Yang, Kebing:
1 article
(10/2018)
|
| 7. | Zhang, Dahong:
1 article
(10/2018)
|
| 8. | Zhang, Qi:
1 article
(10/2018)
|
| 9. | Li, Ning:
1 article
(01/2017)
|
| 10. | Lin, Chunhua:
1 article
(01/2017)
|
Related Diseases
Related Drugs and Biologics